Skip to content
- Teva Pharmaceutical (TEVA) is scheduled to announce Q3 earnings results on Wednesday, November 5th, before market open.
- The consensus EPS Estimate is $0.67 (-2.9% Y/Y) and the consensus revenue estimate is $4.33B (+0.7% Y/Y).
- Over the last 2 years, TEVA has beaten EPS estimates 75% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 4 downward. Revenue estimates have seen 1 upward revision and 5 downward.
